Pharmacology

Latest Content

3D printing in the lab

The biomedical sector is emerging as a key arena for 3D printing technologies, enabling researchers to access new tools to tackle design challenges, explains Ricky Wildman.

In Depth

Knowledge is power: In silico modelling of Covid-19

Scientific research takes time. But, as the Covid-19 pandemic highlighted, sometimes that’s a luxury scientists can’t afford, says ≈. Experimentation and data guide us to the ‘right’ decision based o…

Comment And Analysis

3D printing in the lab

The biomedical sector is emerging as a key arena for 3D printing technologies, enabling researchers to access new tools to tackle design challenges, explains Ricky Wildman.

Interviews

Global focus: the key to infectious disease control

President of the International Society for Infectious Diseases, Professor Paul Ananth Tambyah explains to Rachel Sully the importance of recognising, declaring and responding to infectious diseases s…